CPT 96372: Intramuscular or Subcutaneous Therapeutic/Diagnostic Injection
CPT code 96372 represents the administration of a therapeutic, prophylactic, or diagnostic substance via intramuscular or subcutaneous injection by a physician or supervised clinical staff. This code is widely used across ambulatory care and office-based settings for non-vaccine injections and is a routine procedural billing element for many specialties, including primary care and hematology/oncology. Nationally, accurate use of 96372 affects clinical documentation, revenue capture, and claims adjudication for common injection procedures.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. The publication provides an overview of coverage posture, typical sites of service, coding nuances that distinguish 96372 from device-specific or vaccine-related administration codes, and operational considerations that influence claim outcomes.
Readers will learn: the clinical context and correct clinical scenario for using CPT code 96372; differences between 96372 and related administration codes used for specialized devices; common billing and documentation touchpoints that influence payer decisions; and where to look for policy language or edits that commonly affect payments. Data not available in the input for specific payer reimbursement rates or utilization benchmarks is noted as not provided.
Sign up for cpt 96372 policy alerts
Get alerted when payer policies referencing 96372 are released or updated.
Billing Code Overview
CPT code 96372 describes the intramuscular or subcutaneous injection of a therapeutic, prophylactic, or diagnostic substance administered by a physician, assistant, or nurse under the physician's direct supervision. The code excludes injections of vaccines or toxoids.
Service type: Therapeutic/prophylactic/diagnostic injection.
Typical site of service: Office or outpatient clinic, or other ambulatory care settings where a clinician or supervised staff can perform intramuscular or subcutaneous injections.
Clinical & Coding Specifications
Clinical Context
A 28-year-old patient presents to a family medicine clinic following reported recent sexual exposure to a partner with HIV. The clinician evaluates risk, confirms indication for HIV post‑exposure prophylaxis (PEP) or discussion of pre‑exposure prophylaxis (PrEP) depending on history, and determines the need for an immediate subcutaneous or intramuscular injection of a therapeutic agent (for example, a single‑dose antiretroviral injection when indicated or other prophylactic agent). Under direct physician supervision, a nurse prepares and administers the injection using aseptic technique, documents the drug name, dose, route (IM or SC), lot number, and site, and monitors the patient briefly for immediate adverse reaction before discharge. Typical workflow includes intake and risk assessment, informed consent discussion, medication selection and preparation, administration using 96372 for the IM/SC injection (vaccine/toxoid injections are excluded from this code), post‑administration observation, and documentation of ICD‑10 code Z20.6 for exposure or Z29.81 for PrEP encounter as applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day | Use when a qualifying E/M visit is documented on the same day as 96372 and the visit is distinct from the injection service. |
59 | Distinct procedural service | Use when 96372 is performed in a different anatomical area or during a separate encounter from another procedure and documentation supports distinctness. |
76 | Repeat procedure by same physician | Use if the injection (96372) is repeated later the same day by the same physician. |
77 | Repeat procedure by another physician | Use if the injection is repeated later the same day by a different physician. |
52 | Reduced services | Use when the full service of 96372 is not performed as described and reduction is documented. |
53 | Discontinued procedure | Use if the attempted injection was started but discontinued for documented medical reasons. |
59 | (See above) | (See above) |
90 | Reference (outside) laboratory | Rarely applicable; included when an external lab is referenced in the encounter documentation related to medication testing prior to injection. |
91 | Repeat clinical diagnostic lab test | Rare for 96372; use when lab tests relevant to administration are repeated within the global period and documented. |
GZ | Item or service expected to be denied as not reasonable/necessary | Use only when billing under circumstances where medical necessity is not expected to be met and is reported per payer guidance. |
KX | Requirements specified in the medical policy have been met | Use when payer policy requires attestation that criteria were met for coverage of the injection medication. |
XE | Separate encounter, a subset of modifier 59 | Use when 96372 is performed during a separate encounter on the same day. |
XS | Separate structure, a subset of modifier 59 | Use when injection is administered to a different anatomical structure than another same‑day procedure. |
XP | Separate practitioner, a subset of modifier 59 | Use when a different practitioner performs 96372 than another same‑day procedure. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
208D00000X | Family Medicine | Primary outpatient clinicians who frequently perform or order 96372 in clinic settings for prophylaxis or treatment. |
207RG0100X | Hematology & Oncology | Specialists who may administer therapeutic IM/SC injections for oncologic or hematologic supportive therapies; may use 96372 when appropriate. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
Z29.81 | Encounter for HIV pre‑exposure prophylaxis | Indicates the patient visit relates to PrEP management; 96372 may be used for administration of non‑vaccine prophylactic injections as part of PrEP care when indicated. |
Z20.6 | Contact with and (suspected) exposure to human immunodeficiency virus [HIV] | Used when the encounter is for evaluation after potential HIV exposure; 96372 may be reported for administration of prophylactic or therapeutic IM/SC agents given in that context. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
96377 | Application of on‑body injector (includes cannula insertion) for timed subcutaneous injection | Alternative procedure code used instead of 96372 when an on‑body injector device (e.g., Onpro/ONBODY) is applied rather than a standard IM/SC manual injection. |